clinical trial diversity

BMS puts $300M toward diversity efforts, including clinical trial diversity

by Nile
August 14, 2020

The company plans to train 250 new racially and ethnically diverse clinical trial investigators and extend the reach of its trials to underserved rural and urban communities.

Trials of Gilead’s remdesivir in Covid-19 not diverse enough, experts write

by Nile
August 12, 2020

In a commentary, physicians and pharmacists wrote that percentages of Black, Latino and Native American patients in two Phase III studies of the drug that the company is using for FDA approval were disproportionate to Covid-19’s incidence in those communities.